Abstract: The instant disclosure generally relates to lubricating compositions having an oil of lubricating viscosity, a mixture of boron-containing and boron-free dispersants, an overbased magnesium-based detergent, an overbased calcium-based detergent, a molybdenum-containing material, and, optionally, other performance additives. The instant lubricating compositions may improve one or more of cleanliness, TBN retention, fuel economy and low-speed preignition (“LSPI”).

Abstract: The instant disclosure generally relates to lubricating compositions having an oil of lubricating viscosity, a mixture of boron-containing and boron-free dispersants, an overbased magnesium-based detergent, an overbased calcium-based detergent, an ashless friction modifier, and, optionally, other performance additives. The instant lubricating compositions may improve one or more of cleanliness, TBN retention, fuel economy and low-speed preignition (“LSPI”).

Abstract: The disclosed technology relates to lubricants for compression ignition internal combustion engines, particularly those demonstrating at least one of improved seals performance, reduced deposit formation, and excellent durability. The present invention provides a low zinc lubricating composition comprising (a) an oil of lubricating viscosity, (b) a borated dispersant, and (c) a metal-free organo-phosphorus anti-wear additive, wherein the lubricating composition is substantially free of a metal containing sulfur coupled alkyl phenol compound. Further, the low zinc lubricating composition contains zinc in an amount less than 600 ppm by weight of the composition.

Abstract: The instant disclosure generally relates to lubricating compositions having an oil of lubricating viscosity, a boron-containing additive, a boron-free dispersant, an overbased magnesium-based detergent, an overbased calcium-based detergent, an ashless friction modifier, and, optionally, other performance additives. The instant lubricating composition has a High Temperature High Shear (HTHS) viscosity according to ASTM D4683 of less than 2.7 mPa s. The instant lubricating compositions disclosed herein may accomplish one or more of the following improve fuel economy, reduce corrosion, reduce oxidation, improve cleanliness, and improve wear performance of an internal combustion engine.

Abstract: The instant disclosure generally relates to lubricating compositions having an oil of lubricating viscosity, a mixture of boron-containing and boron-free dispersants, an overbased magnesium-based detergent, an overbased calcium-based detergent, a molybdenum-containing material, and, optionally, other performance additives. The instant lubricating compositions may improve one or more of cleanliness, TBN retention, fuel economy and low-speed preignition (“LSPI”).

Abstract: The invention provides methods of diagnosing and treating multiple sclerosis (MS) patients, including methods of identifying and treating multiple sclerosis patients who are at increased risk of developing a secondary autoimmune disease following lymphocyte depletion, caused, e.g., by treatment with an anti-CD52 antibody. Also embraced are methods of selecting treatment regimens for MS patients, and reagents useful in the above methods.

Abstract: The disclosed technology relates to a dispersant composition comprising the reaction product of a polyolefin acylating agent and a polyamine having a sterically hindered head group. In addition, the technology relates to lubricating compositions containing the dispersant composition and an oil of lubricating viscosity, as well as methods of employing the lubricating composition in an engine and engine oils. Lubricating oils containing the dispersants of the disclosed technology simultaneously achieves seal compatibility, wear, deposit, varnish and corrosion control while also maintaining fuel economy performance over a broad temperature range.

Abstract: The instant disclosure generally relates to lubricating compositions having an oil of lubricating viscosity and a mixed dispersant additive package. The mixed dispersant additive package can include an acylated poly(1-olefin)-based dispersant and a poly-isobutylene succinimide dispersant where the ratio of the acylated poly(1-olefin)-based dispersant to the polyisobutylene succinimide dispersant in the lubricating composition is from 3:1 to 1:3.

Abstract: The invention provides methods of diagnosing and treating multiple sclerosis (MS) patients, including methods of identifying and treating multiple sclerosis patients who are at increased risk of developing a secondary autoimmune disease following lymphocyte depletion, caused, e.g., by treatment with an anti-CD52 antibody. The increased risk may be linked to certain single nucleotide polymorphism genotypes that are indicative of elevated IL-21 levels. Also embraced are methods of selecting treatment regimens for MS patients, and reagents useful in the above methods.

Abstract: The disclosed technology relates to a dispersant composition comprising the reaction product of a polyolefin acylating agent and a polyamine having a sterically hindered head group. In addition, the technology relates to lubricating compositions containing the dispersant composition and an oil of lubricating viscosity, as well as methods of employing the lubricating composition in an engine and engine oils. Lubricating oils containing the dispersants of the disclosed technology simultaneously achieves seal compatibility, wear, deposit, varnish and corrosion control while also maintaining fuel economy performance over a broad temperature range.

Abstract: The disclosed technology relates to lubricants for compression ignition internal combustion engines, particularly those demonstrating at least one of improved seals performance, reduced deposit formation, and excellent durability. The present invention provides a low zinc lubricating composition comprising (a) an oil of lubricating viscosity, (b) a borated dispersant, and (c) a metal-free organo-phosphorus anti-wear additive, wherein the lubricating composition is substantially free of a metal containing sulfur coupled alkyl phenol compound. Further, the low zinc lubricating composition contains zinc in an amount less than 600 ppm by weight of the composition.

Abstract: The disclosed technology relates to lubricants for compression ignition internal combustion engines, particularly those demonstrating at least one of improved seals performance, reduced deposit formation, and excellent durability. The present invention provides a low dispersant lubricating composition comprising (a) an oil of lubricating viscosity, (b) about 0.5 weight percent to 3.0 weight percent of an oxyalkylated hydrocarbyl-substituted phenol compound, (c) about 0.01 weight percent to 2.6 weight percent of a polyalkenylsuccinimide dispersant, and (d) about 0.05 weight percent to 2.0 weight percent of a polyolefin dispersant viscosity modifier, and wherein the lubricating composition contains zinc in an amount less than about 700 ppm by weight of the composition.

Abstract: The invention provides methods of diagnosing and treating multiple sclerosis (MS) patients, including methods of identifying and treating multiple sclerosis patients who are at increased risk of developing a secondary autoimmune disease following lymphocyte depletion, caused, e.g., by treatment with an anti-CD52 antibody. Also embraced are methods of selecting treatment regimens for MS patients, and reagents useful in the above methods.

Abstract: The invention provides methods of diagnosing and treating multiple sclerosis (MS) patients, including methods of identifying and treating multiple sclerosis patients who are at increased risk of developing a secondary autoimmune disease following lymphocyte depletion, caused, e.g., by treatment with an anti-CD52 antibody. Also embraced are methods of selecting treatment regimens for MS patients, and reagents useful in the above methods.

Abstract: The disclosed technology relates to ashless compounds exhibiting neutral pH and having sufficient polarity to act as a dispersant. The disclosed technology additionally relates to the use of the ashless compounds in engine lubricants as dispersants for preventing engine deposit without degrading seals or increasing (i.e. contributing to) corrosion.

Abstract: The disclosed technology relates to a dispersant composition comprising the reaction product of a polyolefin acylating agent and an amine terminated or hydroxyl terminated polyether. In addition, the technology relates to lubricating compositions containing the dispersant composition and an optional synergistic amount of another dispersant, as well as methods of employing the dispersant composition in an engine and engine oils.

Abstract: The disclosed invention relates to a dispersant composition comprising at least one block derived from (i) a polyester of a hydroxy substituted carboxylic acid and at least one block derived from (ii) a polyalkylene glycol terminated by a amine group or a hydroxyl group. The invention also provides lubricating compositions containing the described dispersant as well as methods of making and using the described dispersant, including method of making the dispersant, methods of lubricating an engine with a lubricant containing the described dispersant, and methods of reducing sludge formation in an engine.

Abstract: The disclosed technology relates to a dispersant composition comprising the reaction product of a polyolefin acylating agent and an amine terminated or hydroxyl terminated polyether. In addition, the technology relates to lubricating compositions containing the dispersant composition and an optional synergistic amount of another dispersant, as well as methods of employing the dispersant composition in an engine and engine oils.

Abstract: A composition contains an additive for assisting with the regeneration of the PF in the form of an organic dispersion of iron particles and a detergent including a polyester quaternary ammonium salt.

Abstract: The invention provides methods of diagnosing and treating multiple sclerosis (MS) patients, including methods of identifying and treating multiple sclerosis patients who are at increased risk of developing a secondary autoimmune disease following lymphocyte depletion, caused, e.g., by treatment with an anti-CD52 antibody. Also embraced are methods of selecting treatment regimens for MS patients, and reagents useful in the above methods.